ADDRESS-2 is supporting a study to assess the safety of a new “type 1 diabetes vaccine” designed to stop the immune system from attacking insulin-producing beta cells.
Assessment of a new “type 1 diabetes vaccine” to help preserve insulin production
![Assessment of a new “type 1 diabetes vaccine” to help preserve insulin production Assessment of a new “type 1 diabetes vaccine” to help preserve insulin production](https://www.address2.org/wp-content/uploads/2017/10/cropped-Logo-EXALT-1-200x73.jpg)